Sentry Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$12.9M Sell
122,055
-6,180
-5% -$718K 0.19% 90
2017
Q4
$15M Sell
128,235
-3,090
-2% -$349K 0.19% 94
2017
Q3
$14.9M Sell
131,325
-11,330
-8% -$1.31M 0.15% 92
2017
Q2
$17.8M Sell
142,655
-72,363
-34% -$8.58M 0.13% 89
2017
Q1
$25.5M Sell
215,018
-10,197
-5% -$1.16M 0.18% 78
2016
Q4
$22.6M Sell
225,215
-67,053
-23% -$7.19M 0.17% 78
2016
Q3
$36.9K Sell
292,268
-538,808
-65% -$66.6M 0.31% 63
2016
Q2
$97.1K Sell
831,076
-174,894
-17% -$19.8M 0.91% 28
2016
Q1
$104K Sell
1,005,970
-5,459
-0.5% -$528K 1.26% 25
2015
Q4
$101K Buy
1,011,429
+41,921
+4% +$4.1M 1.16% 27
2015
Q3
$88.4K Buy
969,508
+147,424
+18% +$14.8M 1.07% 28
2015
Q2
$87.2K Buy
822,084
+89,121
+12% +$9.86M 1.02% 29
2015
Q1
$83.6M Buy
732,963
+11,330
+2% +$1.29M 1.06% 33
2014
Q4
$79.5M Buy
721,633
+8,543
+1% +$901K 1% 35
2014
Q3
$69.6M Buy
713,090
+37,513
+6% +$3.69M 0.88% 37
2014
Q2
$68.1M Buy
675,577
+59,740
+10% +$5.83M 0.85% 37
2014
Q1
$56.5M Hold
615,837
0.8% 44
2013
Q4
$55.7M Buy
615,837
+31,621
+5% +$2.74M 0.94% 39
2013
Q3
$46.6M Buy
584,216
+261,002
+81% +$20.5M 0.9% 39
2013
Q2
$23.5M Buy
+323,214
New +$24.2M 0.5% 67

Other funds holding ZBH

Sentry Investments's ZBH Position: Q1 2018 in Review

Sentry Investments reduced its Zimmer Biomet (ZBH) stake by 4.8% in Q1 2018, selling an estimated $718K and leaving 122,055 shares worth $12.9M. The position accounts for 0.19% of the portfolio, ranked #90.

Sentry Investments first reported a position in ZBH in Q2 2013 and has held it in 20 quarters since. The position peaked at $83.6M in Q1 2015. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • Sentry Investments held 122,055 shares of Zimmer Biomet worth $12.9M as of Q1 2018.
  • Sentry Investments sold 6,180 Zimmer Biomet shares in Q1 2018, an estimated $718K.
  • Zimmer Biomet made up 0.19% of Sentry Investments's portfolio in Q1 2018, its #90 holding.
  • Sentry Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 20 quarters since.
  • Sentry Investments's Zimmer Biomet position peaked at $83.6M in Q1 2015.
  • 875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.